BISMUSAL- bismuth subsalicylate suspension 
Durvet, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

BISMUSAL SUSPENSION Anti-Diarrheal Liquid

FOR ANIMAL USE ONLY

KEEP OUT OF REACH OF CHILDREN

FOR ORAL USE ONLY

INDICATIONS

A palatable oral suspension for use as an aid in the control fo simple diarrhea in cattle, horses and dogs.

CONTRAINDICATIONS

Not recommended for use in cats.

CAUTION

This product contains salicylate; do not administer with other salicylate-containing products, such as aspirin.

DOSAGE AND ADMINISTRATION

Administer orally after the first sign of diarrhea and after each loose bowel movement or as needed.

Dogs- 1 to 3 tablespoonfuls

Calves- 3 to 4 ounces

Foals- 3 to 4 ounces

Cattle and Horses- 6-10 fl. ozs.

This product may cause stools to darken.  If diarrhea persists after using this product for 2 days contact veterinarian.

COMPOSITION

Bismuth Subsalicylate ...... 1.75%

in a palatable aqueous suspension.  Flavoring and coloring added.

SHAKE WELL BEFORE USING

Store at room temperature and not above 37°C (98.6°F)

Protect from freezing.

TAKE TIME OBSERVE LABEL DIRECTIONS

Durvet Bismusal

BISMUSAL 
bismuth subsalicylate suspension
Product Information
Product TypeOTC ANIMAL DRUGItem Code (Source)NDC:30798-334
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BISMUTH SUBSALICYLATE (UNII: 62TEY51RR1) (BISMUTH CATION - UNII:ZS9CD1I8YE) BISMUTH SUBSALICYLATE66.2 mg  in 3.785 L
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:30798-334-353.785 L in 1 JUG
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other06/21/200211/10/2022
Labeler - Durvet, Inc. (056387798)

Revised: 11/2022
Document Id: 23e04f1c-cdca-49ef-900b-4c76bd9ed0b1
Set id: 285681f2-914d-41a9-a6fd-d4d9d53cde4c
Version: 6
Effective Time: 20221110
 
Durvet, Inc.